Company / Working Capital per Share
Dexcom Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.91
FY2025
5-year range
$3.50 / $30.84
FY2021-FY2025
Trend
+40.2%
vs FY2024
Sector context
#86 of 158
Health Care
What the data says
At $4.91, Dexcom's working capital per share ranks #86 of 158 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $2.17 in FY2016 to $30.84 in FY2021.
Based on SEC 10-K filings.
4.91 in FY2025 with a 5-year CAGR of -30.0%.
Declined from $7.45 to $4.91 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +1.4%
- 5-Year CAGR
- -30.0%
- 10-Year CAGR
- -
Sector benchmark
#86 of 158 in Health CareTop 54% of 158This company $4.91 Sector average $24.43
▼
-79.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 40.2% year-over-year.
- Ranks #86 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.91 | +40.2% |
| FY2024 | $3.50 | -52.9% |
| FY2023 | $7.45 | +57.9% |
| FY2022 | $4.72 | -84.7% |
| FY2021 | $30.84 | +5.4% |
| FY2020 | $29.25 | +66.5% |
| FY2019 | $17.57 | +3.5% |
| FY2018 | $16.98 | +137.1% |
| FY2017 | $7.16 | +229.4% |
| FY2016 | $2.17 | +2.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026